{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:19:41Z","timestamp":1762867181472,"version":"3.41.2"},"reference-count":110,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK103022"],"award-info":[{"award-number":["R01 DK103022"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2017.00099","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T03:45:08Z","timestamp":1499831108000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Complement in Non-Antibody-Mediated Kidney Diseases"],"prefix":"10.3389","volume":"4","author":[{"given":"Andrea","family":"Angeletti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joselyn","family":"Reyes-Bahamonde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Cravedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirk N.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,7,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1056\/NEJM200104123441506","article-title":"Complement. Second of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.imbio.2016.05.004","article-title":"Role of the lectin complement pathway in kidney transplantation","volume":"221","author":"Farrar","year":"2016","journal-title":"Immunobiology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1084\/jem.160.5.1558","article-title":"Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes","volume":"160","author":"Medof","year":"1984","journal-title":"J Exp Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1084\/jem.166.5.1221","article-title":"The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb","volume":"166","author":"Fujita","year":"1987","journal-title":"J Exp Med"},{"key":"B7","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4049\/jimmunol.142.3.877","article-title":"Decay accelerating factor regulates complement activation on glomerular epithelial cells","volume":"142","author":"Quigg","year":"1989","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/ki.1994.247","article-title":"Localization of the complement regulatory proteins in the normal human kidney","volume":"46","author":"Ichida","year":"1994","journal-title":"Kidney Int"},{"key":"B9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1073\/pnas.82.3.859","article-title":"Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines","volume":"82","author":"Cole","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1084\/jem.181.1.151","article-title":"Mouse complement regulatory protein Crry\/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein","volume":"181","author":"Kim","year":"1995","journal-title":"J Exp Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1172\/JCI72273","article-title":"Complement as a multifaceted modulator of kidney transplant injury","volume":"124","author":"Cravedi","year":"2014","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1161\/CIRCULATIONAHA.113.002972","article-title":"Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-kappaB signaling in endothelial cells","volume":"128","author":"Jane-Wit","year":"2013","journal-title":"Circulation"},{"key":"B13","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1172\/JCI112372","article-title":"Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells","volume":"77","author":"Adler","year":"1986","journal-title":"J Clin Invest"},{"key":"B14","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1146\/annurev.immunol.23.021704.115835","article-title":"Role of C5a in inflammatory responses","volume":"23","author":"Guo","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1084\/jem.20121525","article-title":"Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells","volume":"210","author":"Kwan","year":"2013","journal-title":"J Exp Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5921","DOI":"10.4049\/jimmunol.1300847","article-title":"Cutting edge: receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells","volume":"190","author":"van der Touw","year":"2013","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1016\/j.molimm.2009.04.027","article-title":"The role of the anaphylatoxins in health and disease","volume":"46","author":"Klos","year":"2009","journal-title":"Mol Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1084\/jem.140.1.126","article-title":"Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses","volume":"140","author":"Pepys","year":"1974","journal-title":"J Exp Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1126\/science.271.5247.348","article-title":"C3d of complement as a molecular adjuvant: bridging innate and acquired immunity","volume":"271","author":"Dempsey","year":"1996","journal-title":"Science"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1084\/jem.20041967","article-title":"Decay-accelerating factor modulates induction of T cell immunity","volume":"201","author":"Heeger","year":"2005","journal-title":"J Exp Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.immuni.2008.02.001","article-title":"Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells","volume":"28","author":"Strainic","year":"2008","journal-title":"Immunity"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1182\/blood-2008-04-151068","article-title":"Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis","volume":"112","author":"Lalli","year":"2008","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/ni.2499","article-title":"Absence of signaling into CD4(+) cells via C3aR and C5aR enables autoinductive TGF-beta1 signaling and induction of Foxp3(+) regulatory T cells","volume":"14","author":"Strainic","year":"2013","journal-title":"Nat Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nature01315","article-title":"Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype","volume":"421","author":"Kemper","year":"2003","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/cei.12952","article-title":"Production of complement components by cells of the immune system","volume":"188","author":"Lubbers","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1172\/JCI115314","article-title":"Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells","volume":"88","author":"Brooimans","year":"1991","journal-title":"J Clin Invest"},{"key":"B28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1365-2249.1993.tb08193.x","article-title":"C3 and C4 gene expression and interferon-gamma-mediated regulation in human glomerular mesangial cells","volume":"93","author":"Sacks","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"B29","first-page":"348","article-title":"Complement C3 gene expression and regulation in human glomerular epithelial cells","volume":"79","author":"Sacks","year":"1993","journal-title":"Immunology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1002\/eji.1830231015","article-title":"Interferon-gamma regulation of C4 gene expression in cultured human glomerular epithelial cells","volume":"23","author":"Zhou","year":"1993","journal-title":"Eur J Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nm0602-582","article-title":"Local synthesis of complement component C3 regulates acute renal transplant rejection","volume":"8","author":"Pratt","year":"2002","journal-title":"Nat Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000044876","article-title":"Compartmental localization of complement component transcripts in the normal human kidney","volume":"78","author":"Song","year":"1998","journal-title":"Nephron"},{"key":"B33","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1053\/j.ajkd.2003.10.024","article-title":"Pathologic classification of focal segmental glomerulosclerosis: a working proposal","volume":"43","author":"D\u2019Agati","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1681\/ASN.2012040389","article-title":"Treatment of primary FSGS in adults","volume":"23","author":"Korbet","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/ndt\/14.suppl_3.68","article-title":"Clinical picture and outcome of primary focal segmental glomerulosclerosis","volume":"14","author":"Korbet","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"B36","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/ki.2010.398","article-title":"Testosterone and 17beta-estradiol have opposite effects on podocyte apoptosis that precedes glomerulosclerosis in female estrogen receptor knockout mice","volume":"79","author":"Doublier","year":"2011","journal-title":"Kidney Int"},{"key":"B37","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/ajt.12045","article-title":"Recent progress in the pathophysiology and treatment of FSGS recurrence","volume":"13","author":"Cravedi","year":"2013","journal-title":"Am J Transplant"},{"key":"B38","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/ckj\/sfv090","article-title":"A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continues","volume":"8","author":"Wada","year":"2015","journal-title":"Clin Kidney J"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1172\/JCI20402","article-title":"Induction of B7-1 in podocytes is associated with nephrotic syndrome","volume":"113","author":"Reiser","year":"2004","journal-title":"J Clin Invest"},{"key":"B40","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/ki.2013.549","article-title":"Are serum suPAR determinations by current ELISA methodology reliable diagnostic biomarkers for FSGS?","volume":"85","author":"Schlondorff","year":"2014","journal-title":"Kidney Int"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1056\/NEJMe1512997","article-title":"A suPAR biomarker for chronic kidney disease","volume":"373","author":"Skorecki","year":"2015","journal-title":"N Engl J Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nm.4242","article-title":"Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease","volume":"23","author":"Hahm","year":"2017","journal-title":"Nat Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"F555","DOI":"10.1152\/ajprenal.00403.2006","article-title":"The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy","volume":"293","author":"Lenderink","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.4049\/jimmunol.177.6.4094","article-title":"Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice","volume":"177","author":"Turnberg","year":"2006","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"28445","DOI":"10.1038\/srep28445","article-title":"A previously unrecognized role of C3a in proteinuric progressive nephropathy","volume":"6","author":"Morigi","year":"2016","journal-title":"Sci Rep"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1172\/JCI36000","article-title":"Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells","volume":"119","author":"Bao","year":"2009","journal-title":"J Clin Invest"},{"key":"B47","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1681\/ASN.2012020187","article-title":"IgM contributes to glomerular injury in FSGS","volume":"24","author":"Strassheim","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e0136558","DOI":"10.1371\/journal.pone.0136558","article-title":"Complement activation in patients with focal segmental glomerulosclerosis","volume":"10","author":"Thurman","year":"2015","journal-title":"PLoS One"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/ki.2013.377","article-title":"C3 glomerulopathy: consensus report","volume":"84","author":"Pickering","year":"2013","journal-title":"Kidney Int"},{"key":"B50","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nrneph.2010.85","article-title":"C3 glomerulopathy: a new classification","volume":"6","author":"Fakhouri","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2215\/CJN.04700513","article-title":"C3 glomerulopathy: clinicopathologic features and predictors of outcome","volume":"9","author":"Medjeral-Thomas","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1681\/ASN.2015060612","article-title":"Mayo clinic\/renal pathology society consensus report on pathologic classification, diagnosis, and reporting of GN","volume":"27","author":"Sethi","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ki.2012.63","article-title":"Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies","volume":"82","author":"Servais","year":"2012","journal-title":"Kidney Int"},{"key":"B54","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/ki.2011.399","article-title":"Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion","volume":"81","author":"Sethi","year":"2012","journal-title":"Kidney Int"},{"key":"B55","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/MNH.0b013e328345848b","article-title":"Complement and glomerular disease: new insights","volume":"20","author":"Pickering","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.molimm.2011.04.005","article-title":"Dense deposit disease","volume":"48","author":"Smith","year":"2011","journal-title":"Mol Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201ckidney disease: improving global outcomes\u201d (KDIGO) controversies conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"key":"B58","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000368592","article-title":"Eculizumab in the treatment of membranoproliferative glomerulonephritis","volume":"128","author":"Bomback","year":"2014","journal-title":"Nephron Clin Pract"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1053\/j.ajkd.2010.06.006","article-title":"The role of endothelial cell injury in thrombotic microangiopathy","volume":"56","author":"Goldberg","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"B61","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrneph.2012.195","article-title":"STEC-HUS, atypical HUS and TTP are all diseases of complement activation","volume":"8","author":"Noris","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/j.1538-7836.2005.01205.x","article-title":"Shiga toxin enhances functional tissue factor on human glomerular endothelial cells: implications for the pathophysiology of hemolytic uremic syndrome","volume":"3","author":"Nestoridi","year":"2005","journal-title":"J Thromb Haemost"},{"key":"B63","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S0140-6736(73)92645-7","article-title":"Letter: plasma-C3 in haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura","volume":"2","author":"Cameron","year":"1973","journal-title":"Lancet"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S0140-6736(73)92782-7","article-title":"Letter: serum-complement levels in haemolytic-uraemic syndrome","volume":"2","author":"Kaplan","year":"1973","journal-title":"Lancet"},{"key":"B65","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0140-6736(74)91463-9","article-title":"Letter: serum-complement levels in haemolytic-uraemic syndrome","volume":"2","author":"Monnens","year":"1974","journal-title":"Lancet"},{"key":"B66","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1159\/000187063","article-title":"Hypocomplementemia and leukocytosis in diarrhea-associated hemolytic uremic syndrome","volume":"62","author":"Robson","year":"1992","journal-title":"Nephron"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1056\/NEJMc1100859","article-title":"Eculizumab in severe Shiga-toxin-associated HUS","volume":"364","author":"Lapeyraque","year":"2011","journal-title":"N Engl J Med"},{"key":"B68","first-page":"168","article-title":"The complement system in hemolytic-uremic syndrome in childhood","volume":"13","author":"Monnens","year":"1980","journal-title":"Clin Nephrol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.2215\/CJN.02730409","article-title":"Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome","volume":"4","author":"Thurman","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1182\/blood-2010-09-309161","article-title":"Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome","volume":"117","author":"Stahl","year":"2011","journal-title":"Blood"},{"key":"B71","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4049\/jimmunol.1100491","article-title":"Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis","volume":"187","author":"Morigi","year":"2011","journal-title":"J Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1084\/jem.20041497","article-title":"Platelet activation leads to activation and propagation of the complement system","volume":"201","author":"Del Conde","year":"2005","journal-title":"J Exp Med"},{"key":"B73","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.molimm.2015.03.246","article-title":"Atypical aHUS: state of the art","volume":"67","author":"Nester","year":"2015","journal-title":"Mol Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood"},{"key":"B76","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1182\/blood-2008-02-078170","article-title":"Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura","volume":"112","author":"Sadler","year":"2008","journal-title":"Blood"},{"key":"B77","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1182\/blood-2002-05-1397","article-title":"Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13)","volume":"100","author":"Plaimauer","year":"2002","journal-title":"Blood"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.2215\/CJN.01700215","article-title":"ADAMTS13 secretion and residual activity among patients with congenital thrombotic thrombocytopenic purpura with and without renal impairment","volume":"10","author":"Rurali","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1160\/TH04-07-0450","article-title":"Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies","volume":"93","author":"Ruiz-Torres","year":"2005","journal-title":"Thromb Haemost"},{"key":"B80","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1538-7836.2012.04674.x","article-title":"Complement activation in thrombotic thrombocytopenic purpura","volume":"10","author":"Reti","year":"2012","journal-title":"J Thromb Haemost"},{"key":"B81","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nrneph.2011.149","article-title":"Cellular and molecular mechanisms of renal fibrosis","volume":"7","author":"Liu","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1096\/fj.07-8719com","article-title":"Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury","volume":"22","author":"Sheerin","year":"2008","journal-title":"FASEB J"},{"key":"B83","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1681\/ASN.2008040434","article-title":"C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy","volume":"20","author":"Tang","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"F957","DOI":"10.1152\/ajprenal.00344.2013","article-title":"Complement 3 activates the renal renin-angiotensin system by induction of epithelial-to-mesenchymal transition of the nephrotubulus in mice","volume":"305","author":"Zhou","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1681\/ASN.2006121343","article-title":"Complement C5 mediates experimental tubulointerstitial fibrosis","volume":"18","author":"Boor","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1111\/j.1523-1755.2004.00957.x","article-title":"C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis","volume":"66","author":"Rangan","year":"2004","journal-title":"Kidney Int"},{"key":"B87","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.kint.2016.04.023","article-title":"The complement factor 5a receptor 1 has a pathogenic role in chronic inflammation and renal fibrosis in a murine model of chronic pyelonephritis","volume":"90","author":"Choudhry","year":"2016","journal-title":"Kidney Int"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/nbt1207-1488c","article-title":"Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria","volume":"25","author":"Rother","year":"2007","journal-title":"Nat Biotechnol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1056\/NEJMc1106619","article-title":"Eculizumab and refractory membranoproliferative glomerulonephritis","volume":"366","author":"Radhakrishnan","year":"2012","journal-title":"N Engl J Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMc1111953","article-title":"Eculizumab for the treatment of dense-deposit disease","volume":"366","author":"Vivarelli","year":"2012","journal-title":"N Engl J Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1056\/NEJMc1112273","article-title":"Eculizumab in a patient with dense-deposit disease","volume":"366","author":"Daina","year":"2012","journal-title":"N Engl J Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1111\/j.1600-6143.2011.03923.x","article-title":"Recurrent dense deposit disease after renal transplantation: an emerging role for complementary therapies","volume":"12","author":"McCaughan","year":"2012","journal-title":"Am J Transplant"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s00467-013-2565-x","article-title":"Evolution of immunoglobulin deposition in C3-dominant membranoproliferative glomerulopathy","volume":"28","author":"Kerns","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1007\/s00467-013-2503-y","article-title":"Eculizumab and recurrent C3 glomerulonephritis","volume":"28","author":"Gurkan","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s00467-013-2711-5","article-title":"Rituximab fails where eculizumab restores renal function in C3nef-related DDD","volume":"29","author":"Rousset-Rouviere","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s00467-013-2748-5","article-title":"Eculizumab therapy in a patient with dense-deposit disease associated with partial lipodystrophy","volume":"29","author":"Ozkaya","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00467-017-3619-2","article-title":"C3 glomerulopathy and eculizumab: a report on four paediatric cases","volume":"32","author":"Lebreton","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1681\/ASN.2011121186","article-title":"Pathology after eculizumab in dense deposit disease and C3 GN","volume":"23","author":"Herlitz","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"748","DOI":"10.2215\/CJN.12901211","article-title":"Eculizumab for dense deposit disease and C3 glomerulonephritis","volume":"7","author":"Bomback","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.4049\/jimmunol.1101000","article-title":"Ornithodoros moubata complement inhibitor is an equally effective C5 inhibitor in pigs and humans","volume":"187","author":"Barratt-Due","year":"2011","journal-title":"J Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.smim.2016.05.001","article-title":"Therapeutic complement inhibition in complement-mediated hemolytic anemias: past, present and future","volume":"28","author":"Risitano","year":"2016","journal-title":"Semin Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016111179","article-title":"Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis","author":"Jayne","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.molimm.2008.09.026","article-title":"Complement receptor 1: disease associations and therapeutic implications","volume":"46","author":"Khera","year":"2009","journal-title":"Mol Immunol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1084\/jem.159.6.1669","article-title":"Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1","volume":"159","author":"Medof","year":"1984","journal-title":"J Exp Med"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1681\/ASN.2013010045","article-title":"Soluble CR1 therapy improves complement regulation in C3 glomerulopathy","volume":"24","author":"Zhang","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/sj.bjp.0706286","article-title":"APT070 (Mirococept), a membrane-localised complement inhibitor, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury","volume":"145","author":"Souza","year":"2005","journal-title":"Br J Pharmacol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1681\/ASN.2005101116","article-title":"Therapeutic strategy with a membrane-localizing complement regulator to increase the number of usable donor organs after prolonged cold storage","volume":"17","author":"Patel","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3324\/haematol.2016.153312","article-title":"Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome","volume":"102","author":"Yuan","year":"2017","journal-title":"Haematologica"},{"key":"B110","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/MNH.0000000000000305","article-title":"Breaking down the complement system: a review and update on novel therapies","volume":"26","author":"Reddy","year":"2017","journal-title":"Curr Opin Nephrol Hypertens"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00099\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T12:12:29Z","timestamp":1692879149000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00099\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,12]]},"references-count":110,"alternative-id":["10.3389\/fmed.2017.00099"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2017.00099","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2017,7,12]]},"article-number":"99"}}